Published on
Mar 22, 2025
A jab that could protect against HIV for a year at a time
A new lenacapavir study suggests annual HIV prevention dose; phase three study expected later this year. Lenacapavir injections maintain drug levels for 12 months, exceeding current biannual doses. Gilead might submit results by 2027; European Medicines …
Source:
News24
-
Neutral
